14
October
2022
|
09:30 AM
Europe/Amsterdam
Not intended for U.S. and UK Media
Summary
Mirena® (52mg LNG IUS), Bayer’s long-acting reversible intrauterine system, received regulatory approval in the European Workshare Procedure for up to eight years in contraception, now offering the longest contraceptive duration of use for any hormonal intrauterine system – national approvals expected in Q4 / The IUS is one of the most effective birth control methods / Mirena was also approved for the treatment of idiopathic menorrhagia (heavy menstrual bleeding) for up to eight years if symptoms have not returned earlier
Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here